SCHEMBL15912919

SCHEMBL15912919

Nc1cnc(-c2ccc(Cl)c(OCc3ccccc3)c2)cn1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 6/20 0.69
FEN1 P39748 7/20 0.65
MGAM O43451 1/20 0.58
GAA P10253 1/20 0.58
SI P14410 1/20 0.58
MGAM2 Q2M2H8 1/20 0.58
MAP4K4 O95819 1/20 0.44
CTSA P10619 1/20 0.44
KDM4C Q9H3R0 2/20 0.43
SYK P43405 1/20 0.41
PTGER1 P34995 1/20 0.41
PLAU P00749 1/20 0.41
LTA4H P09960 1/20 0.40
MAPK14 Q16539 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP11B1 P15538 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15913213 0.81 ALOX5AP (1.00) ALOX5APFEN1MGAMGAASI
SCHEMBL15913079 0.79 FEN1 (1.00) ALOX5APFEN1
SCHEMBL15912858 0.76 ALOX5AP (0.51) ALOX5APFEN1MAP4K4PIK3CDPIK3CA
SCHEMBL11189337 0.75 LTA4H (0.49) ALOX5APFEN1MGAMGAASI
SCHEMBL4194593 0.74 SYK (0.63) MGAMGAASIMGAM2SYK
SCHEMBL11372102 0.74 KMO (0.59) ALOX5APFEN1PIK3CDPIK3CAPIK3CB
SCHEMBL27772805 0.74 PTGER1 (0.60) MGAMGAASIMGAM2CTSA
SCHEMBL15912845 0.73 FEN1 (1.00) ALOX5APFEN1
SCHEMBL8611382 0.72 ALOX5AP (0.47) ALOX5APFEN1MGAMGAASI
SCHEMBL17589345 0.71 MRGPRX4 (0.66) MGAMGAASIMGAM2PTGER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951169-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-08-28 EP disclosed
US-9926333-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2018-03-27 US disclosed
US-20170327514-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-11-16 US disclosed
US-9732093-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-15 US disclosed
US-20150368270-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-24 US disclosed
EP-2951169-A1 FLAP MODULATORS Janssen Pharmaceutica, N.V. (BE) 2015-12-09 EP disclosed
US-20150252008-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-10 US disclosed
US-9073876-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-07 US disclosed
WO-2014121040-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-08-07 WO disclosed
US-20140221310-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327514-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 70/4885FEN1 1/4885MGAM 2709/4885
US-20140221310-A1 FLAP MODULATORS FEN1, PGF, PTGIS ALOX5AP 61/4885FEN1 1/4885MGAM 2741/4885
US-20150368270-A1 FLAP MODULATORS FEN1, PGF, TBXA2R ALOX5AP 70/4885FEN1 1/4885MGAM 2709/4885
US-20150252008-A1 FLAP MODULATORS FEN1, PGF, PTGIS ALOX5AP 61/4885FEN1 1/4885MGAM 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.